符合线路正电子成像检测存活心肌的临床应用研究进展
刘德芳,王荣福
摘要(Abstract)：
关键词(KeyWords)：
基金项目(Foundation):
作者(Author): 刘德芳,王荣福
参考文献(References)：
- 1BermanDS ,GermanoG ,ShawLJ.Theroleofnuclearcardiologyinclinicaldecisionmaking.SeminNuclMed,1999,29:280297.
- 2王荣福,李路平.符合线路断层显像原理及其应用.核电子学与探测技术,2002,22:567571
- 3王荣福,胡怀湘,范岩,等.18F FDG分子符合成像在肿瘤诊断中的临床价值.中国医学影像技术杂志,2002,18:631633.
- 4付占立,林景辉,王荣福,等.衰减校正在18F FDGSPECT显像中的价值.中华核医学杂志,2002,22:4042.
- 5PattonJA ,TurkingtonTG .Coincidenceimagingwithadual headscintillationcamera.JNuclMed,1999,40:432441.
- 6GopalS ,AnastasiaNK ,StephenLB ,etal.18 F FluorodeoxyglucoseSinglePhotonEmissionComputedTomographyCanItReplacePETandThalliumSPECTfortheAssessmentofMyocardialViability?Circulation,1998,97:843850.
- 7沈锐,刘秀杰,史蓉芳,等.门控99mTc18F FDG双核素同时采集显像评价左心室功能.中华核医学杂志,2002,22:263265.
- 8BolliR .Mechanismofmyocardial“stunning”.Circulation,1990,82:723738.
- 9PeprettaM ,CampaW ,CuocdoA .Myocardialviabilityassessmentinregionsofleftventriculardysfunction.PartⅠ:Radionuclideimagingandclinicalimplications.NuclMedCommun,2001,22:607611.
- 10BodenWE ,BrooksWW ,ConradCH .Incomplete,delayedfunctionalrecoverylateafterreperfusionfollowingacutemyocardialinfarction:“aiaedmyocardium”.AmHeartJ,1995,130:922932.
- 11DepueyEG ,GhesaniM .SchwartzM ,etal.ComparativeperformanceofgatedperfusionSPECTwalllthickening,delayedthalliumuptakeandF 18fluorodeoxyglucoseSPECTindetectingmyocardialviability.NuclCardiol,1999,6:418428.
- 12SchinkelAFL ,BaxJJ,ValkemaRetal.Effectofdiabetesmellitusonmyocardial18F FDGSPECTusingacipimoxfortheassessmentofmyocardialviability.JNuclMed,2003,44:877883.
- 13王荣福主编.核医学.北京:北京大学医学出版社,2003.4159.
- 14刘金耀,郭朝华.多巴酚丁胺超声心动图检测缺血后存活心肌.中华超声影像学杂志,1998,7:142144.
- 15YoshinagaK ,MoritaK ,YamadaS ,etal.Low dosedobutamineelectrocardialgraph gatedmyocardialSPECTforidentifyingviablemyocardium:comparisonwithdobutaminestressechocardiographyandPET .JNuclMed,2001,42:838845.
- 16金善,楮骏仁,李志善,等.门控与非门控心肌断层显像诊断价值的比较.中华核医学杂志,1995,15:252253.
- 17LevineMG ,McGillCC ,AhlbergAW ,etal.FunctionalassessmentwithelectrocardiographicgatedSPECTimprovestheabilityoftechnetium99msestamibimyocardialviabilityinpatientsundergoingrevascularization.AmJCardiol,1999,83:15.
- 18VomDahlJ ,AltehoeferC ,BiedermannM ,etal.Technetium99mmethoxy isobuty isonitrileasatracerofmyocardialviability?aquantitativecomparisonwithF 18FDGin100patientswithcoronaryarterydisease.AmCollCardiol,1993,21(supplA):283A .
- 19LeppoJA ,DepueyEG ,JohnsonLL .Areviewofcardiacwithsestamibiandteboroxime.JNuclMed,1991,32:20122022.
- 20MachacJ .Technetium99misonitrile:aperfusionoraviabilityagent?AmCollCardiol,1989,14:16851688.
- 21SchaeferWM ,NowakB ,KaiserHJ ,etal.ComparisonofMicrosphereEquivalentBloodFlow((15)O WaterPET)andRelativePerfusion((99m)TcTetrofosminSPECT)inMyocardiumShowingMetabolismPerfusionMismatch.JNuclMed,2003,44:3340.
- 22SouferR .ComparisonofsestamibiSPECTwithPETforestimatingleftventricularmyocardialviability.AmJCardiol,1995,75:12141219.
- 23MartinWM .FDG SPECT :correctionwithFDG PET .JNuclMed,1995,36:988995.
- 24YmashitaK ,TamakiN ,YonikuraY ,etal.Regionalwallthickeningofleftventricleevaluatedbygatedpositronemissiontomographyinrelationtomyocardialperfusionandgluosemetabolism.JNuclMed,1991,32:679685.
- 25DepueyEG ,GhesaniM .SchwartzM ,etal.ComparativeperformanceofgatedperfusionSPECTwallthickening,delayedthalliumuptakeandF 18fluorodeoxyglucoseSPECTindetectingmyocardialviability.NuclCardiol,2000,7:461470.
- 26MatsunariI,YoneyamaT ,KanayamaS ,etal.Phantomstudiesforestimationofdefectsizeoncardiac(18)FSPECTandPET :Implicationsformyocardialviabilityassessment.JNuclMed,2001,42:15791586.
- 27SchinkelAFL ,BaxJJ,SozziFB ,etal.Prevalenceofmyocardialviabilityassessedbysinglephotonemissioncomputedtomographyinpatientswithchronicischaemicventriculardysfunction.Heart,2002,88:125131.